Lindner, Thomas
Loktev, Anastasia
Giesel, Frederik
Kratochwil, Clemens
Altmann, Annette
Haberkorn, Uwe
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (13N 13341)
Article History
Received: 5 February 2019
Accepted: 16 July 2019
First Online: 25 July 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Patent application (EP 18155420.5) for quinolone based FAP targeting agents for imaging and therapy in nuclear medicine (UH, AL, and TL).